NM_002905.5:c.600C>G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_002905.5(RDH5):​c.600C>G​(p.Val200Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0523 in 1,613,962 control chromosomes in the GnomAD database, including 6,787 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. V200V) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.13 ( 2700 hom., cov: 32)
Exomes 𝑓: 0.044 ( 4087 hom. )

Consequence

RDH5
NM_002905.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.945

Publications

12 publications found
Variant links:
Genes affected
RDH5 (HGNC:9940): (retinol dehydrogenase 5) This gene encodes an enzyme belonging to the short-chain dehydrogenases/reductases (SDR) family. This retinol dehydrogenase functions to catalyze the final step in the biosynthesis of 11-cis retinaldehyde, which is the universal chromophore of visual pigments. Mutations in this gene cause autosomal recessive fundus albipunctatus, a rare form of night blindness that is characterized by a delay in the regeneration of cone and rod photopigments. Alternative splicing results in multiple transcript variants. Read-through transcription also exists between this gene and the neighboring upstream BLOC1S1 (biogenesis of lysosomal organelles complex-1, subunit 1) gene. [provided by RefSeq, Dec 2010]
CD63 (HGNC:1692): (CD63 molecule) The protein encoded by this gene is a member of the transmembrane 4 superfamily, also known as the tetraspanin family. Most of these members are cell-surface proteins that are characterized by the presence of four hydrophobic domains. The proteins mediate signal transduction events that play a role in the regulation of cell development, activation, growth and motility. The encoded protein is a cell surface glycoprotein that is known to complex with integrins. It may function as a blood platelet activation marker. Deficiency of this protein is associated with Hermansky-Pudlak syndrome. Also this gene has been associated with tumor progression. Alternative splicing results in multiple transcript variants encoding different protein isoforms. [provided by RefSeq, Apr 2012]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.47).
BP6
Variant 12-55723916-C-G is Benign according to our data. Variant chr12-55723916-C-G is described in ClinVar as Benign. ClinVar VariationId is 258858.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.945 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.334 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002905.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RDH5
NM_002905.5
MANE Select
c.600C>Gp.Val200Val
synonymous
Exon 4 of 5NP_002896.2
RDH5
NM_001199771.3
c.600C>Gp.Val200Val
synonymous
Exon 4 of 5NP_001186700.1
CD63
NM_001413284.1
c.*1148G>C
3_prime_UTR
Exon 9 of 9NP_001400213.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RDH5
ENST00000257895.10
TSL:1 MANE Select
c.600C>Gp.Val200Val
synonymous
Exon 4 of 5ENSP00000257895.6
RDH5
ENST00000548082.1
TSL:1
c.600C>Gp.Val200Val
synonymous
Exon 4 of 5ENSP00000447128.1
ENSG00000258311
ENST00000550412.5
TSL:2
c.*2210C>G
3_prime_UTR
Exon 4 of 4ENSP00000447650.1

Frequencies

GnomAD3 genomes
AF:
0.131
AC:
19905
AN:
152126
Hom.:
2693
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.339
Gnomad AMI
AF:
0.0614
Gnomad AMR
AF:
0.170
Gnomad ASJ
AF:
0.0662
Gnomad EAS
AF:
0.0275
Gnomad SAS
AF:
0.0616
Gnomad FIN
AF:
0.0322
Gnomad MID
AF:
0.108
Gnomad NFE
AF:
0.0287
Gnomad OTH
AF:
0.113
GnomAD2 exomes
AF:
0.0821
AC:
20639
AN:
251260
AF XY:
0.0713
show subpopulations
Gnomad AFR exome
AF:
0.345
Gnomad AMR exome
AF:
0.218
Gnomad ASJ exome
AF:
0.0647
Gnomad EAS exome
AF:
0.0265
Gnomad FIN exome
AF:
0.0291
Gnomad NFE exome
AF:
0.0291
Gnomad OTH exome
AF:
0.0684
GnomAD4 exome
AF:
0.0441
AC:
64532
AN:
1461718
Hom.:
4087
Cov.:
31
AF XY:
0.0431
AC XY:
31349
AN XY:
727174
show subpopulations
African (AFR)
AF:
0.344
AC:
11524
AN:
33476
American (AMR)
AF:
0.209
AC:
9350
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.0618
AC:
1614
AN:
26134
East Asian (EAS)
AF:
0.0189
AC:
750
AN:
39698
South Asian (SAS)
AF:
0.0631
AC:
5440
AN:
86250
European-Finnish (FIN)
AF:
0.0283
AC:
1506
AN:
53284
Middle Eastern (MID)
AF:
0.104
AC:
600
AN:
5768
European-Non Finnish (NFE)
AF:
0.0271
AC:
30166
AN:
1111996
Other (OTH)
AF:
0.0593
AC:
3582
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
3508
7015
10523
14030
17538
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1434
2868
4302
5736
7170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.131
AC:
19936
AN:
152244
Hom.:
2700
Cov.:
32
AF XY:
0.130
AC XY:
9708
AN XY:
74458
show subpopulations
African (AFR)
AF:
0.338
AC:
14034
AN:
41492
American (AMR)
AF:
0.171
AC:
2612
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0662
AC:
230
AN:
3472
East Asian (EAS)
AF:
0.0276
AC:
143
AN:
5180
South Asian (SAS)
AF:
0.0617
AC:
298
AN:
4830
European-Finnish (FIN)
AF:
0.0322
AC:
342
AN:
10630
Middle Eastern (MID)
AF:
0.105
AC:
31
AN:
294
European-Non Finnish (NFE)
AF:
0.0287
AC:
1953
AN:
68018
Other (OTH)
AF:
0.112
AC:
237
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
752
1504
2255
3007
3759
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
186
372
558
744
930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0316
Hom.:
51
Bravo
AF:
0.151
Asia WGS
AF:
0.0580
AC:
204
AN:
3478
EpiCase
AF:
0.0327
EpiControl
AF:
0.0303

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
-
1
not specified (1)
-
-
1
Pigmentary retinal dystrophy (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.47
CADD
Benign
9.9
DANN
Benign
0.79
PhyloP100
-0.94
Mutation Taster
=94/6
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs13193; hg19: chr12-56117700; API